Related Experiment Video
Updated: May 12, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Regulating the fate of tumor-associated macrophages
Elina Timosenko1, Dmitry I Gabrilovich2
1ICC, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK.
Abstract:
Tumor-associated macrophages (TAMs) are key players in tumor progression, yet their role in this process remains only partially understood. In this issue of Cancer Cell, Sheban et al. demonstrate that zinc finger E-box-binding homeobox 2 (ZEB2) acts as a master regulator that reprograms TAMs toward a pro-tumor phenotype and that therapeutic targeting of ZEB2 exhibits anti-tumor activity.
Insights
Zinc finger E-box-binding homeobox 2 (ZEB2) reprograms tumor-associated macrophages (TAMs) to promote cancer. Targeting ZEB2 effectively reduces tumor growth, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor-associated macrophages (TAMs) are crucial in cancer progression.
- The precise mechanisms by which TAMs promote tumors are not fully understood.
Purpose of the Study:
- To investigate the role of ZEB2 in regulating TAM function.
- To explore the therapeutic potential of targeting ZEB2 in cancer.
Main Methods:
- Analysis of ZEB2 expression in TAMs.
- Functional studies involving ZEB2 manipulation in macrophages.
- Assessment of anti-tumor activity following ZEB2 inhibition in preclinical models.
Main Results:
- ZEB2 identified as a master regulator reprogramming TAMs towards a pro-tumorigenic phenotype.
- Therapeutic targeting of ZEB2 demonstrated significant anti-tumor activity.
Conclusions:
- ZEB2 plays a critical role in orchestrating the pro-tumor functions of TAMs.
- Targeting ZEB2 represents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
The Tumor Microenvironment
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mesenchymal Stem Cells

